Ming Y Lim: The Burden and Impact of Bleeding in Newly Diagnosed Cancer Patients
Ming Y Lim, Clinical Associate Professor at the University of Utah, shared on LinkedIn about a recent article she and her colleagues co-authored, published in AJH, adding
”There is substantial focus on the prevention and management of cancer-associated thrombosis given its high prevalence and well-established impact on cancer outcomes.
However, as a hematologist, I am equally consulted for cancer-associated bleeding; an issue that is just as common but remains underrecognized by both oncologists and hematologists.
Notably, there is a paucity of data describing the incidence of bleeding in patients with newly diagnosed cancer, as most prior studies have focused on bleeding in the context of anticoagulation for cancer-associated thrombosis.
In this study, we analyzed over 2.4 million patients with newly diagnosed cancer across U.S. health systems.
We found that the cumulative incidence of clinically relevant bleeding (CRB) was 6.3% within the first year after cancer diagnosis.
Similar to thrombosis, the risk of CRB was higher among patients with advanced disease, greater comorbidity burden, recent hospitalizations, and those receiving systemic therapy.
Importantly, bleeding events were independently associated with increased mortality, particularly intracranial and gastrointestinal hemorrhage.
These findings highlight that bleeding risk in cancer patients is substantial and comparable in magnitude to thrombotic risk.
This underscores an urgent need for validated bleeding risk models that can be integrated alongside thrombosis prediction tools to guide safer, more personalized thromboprophylaxis strategies in cancer care.”
Title: Clinically Relevant Bleeding in Individuals With Cancer: Insights From a Nationwide Cohort Study
Authors: Ming Y. Lim, Radhika Gangaraju, Omid Jafari, Zihan Yang, Joyce W. T. Tiong, Elizabeth C. L. Chiang, Shengling Ma, Jun Y. Jiang, Justine Ryu, Barbara D. Lam, Mrinal Ranjan, Ang Li
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 7, 2026, 14:16What Would You Like to Know About Hemophilia Gene Therapy? – ISTH
-
Jun 7, 2026, 14:10Kamran Hajiyev: Reflections from The ICCA Stroke 2026
-
Jun 7, 2026, 14:08Faham Raza Jaffary: Beyond the Workplace – Driving Community Engagement and Empathy
-
Jun 7, 2026, 14:04Mayank Dwivedi: Transforming Outcomes Through Speed and Innovation In Stroke
-
Jun 7, 2026, 14:03Alejandro Gonzalez Veliz: What If Inflammation Is the Hidden Driver of Cardiovascular Disease?
-
Jun 7, 2026, 13:59Ghanim Ullah: Determining the Role of NCX1 in Neurons and Astrocytes During Ischemic Stroke
-
Jun 7, 2026, 13:51Billy Alexander: Learning from Volunteers as I Begin My Journey with the Stroke Association Scotland
-
Jun 7, 2026, 12:28Thrombosis in Cancer Patients: Why It Happens and How We Treat It Today
-
Jun 7, 2026, 12:01Addressing Real-World Challenges in Thrombosis Care Through Case-Based Learning – Thrombosis Canada